Home / Pharmaceutical company intelligence
NovaMed Pharmaceuticals(Pvt.)Ltd logo
Pharmaceutical company intelligence

NovaMed Pharmaceuticals products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Lahore · Pakistan

Lahore-based pharmaceutical manufacturer and marketer with local, toll-manufacturing and export operations across multiple dosage forms.

NovaMed Pharmaceuticals products in Pakistan

NovaMed Pharmaceuticals(Pvt.)Ltd has 185 medicine presentations registered in Pakistan under 74 brands, covering 61 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Hematology & thrombosis. Its brands with the most registered strengths and packs are Taboxa (Rivaroxaban), Ciprojan (Ciprofloxacin), O-Zole (Omeprazole) and Arithro (Clarithromycin). 185 products have an official DRAP price on MedInfoBase. See all 74 brands A to Z

Database-driven profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public source rechecked
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Oct 2026Latest source-check date across this published portfolio
Latest effective price date5 Aug 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Oct 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public source rechecked
Legal / official name
NovaMed Pharmaceuticals (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
28-KM Ferozpur Road, Lahore, Pakistan
Phone
+92 42 35403360-4
Official contact
Contact page ↗
Corporate source details checked
16 Oct 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000590 NovaMed Pharmaceuticals (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000590 185 linked products · source seen 11 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx205public portfolio records represented
REG149unique registrations represented
IDX185indexed MedInfoBase presentations
SRC1additional source-observed presentations
R+19registry-only registrations
VER89registry-verified exact registrations
PKR185current validated price records
G61generic molecules in indexed catalogue
DF10dosage-form groups
TA13therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage90%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage98%
priced packs safely normalized per unit
Comparable-market coverage92%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixNovaMed Pharmaceuticals(Pvt.)LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/novamed-pharmaceuticalspvt-ltdGenerated 11 Nov 2026Anti-infectives95 · 51%Cardiovascular20 · 11%Hematology & thrombosis16 · 9%Vitamins, minerals & nutrition12 · 6%Endocrine & metabolic11 · 6%Pain & musculoskeletal11 · 6%Gastrointestinal & hepatology7 · 4%Other therapeutic areas13 · 7%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioNovaMed Pharmaceuticals(Pvt.)LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/novamed-pharmaceuticalspvt-ltdGenerated 11 Nov 2026185presentationsTablet95 · 51%Injection30 · 16%Capsule21 · 11%Suspension17 · 9%Infusion7 · 4%Cream6 · 3%Other forms9 · 5%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionNovaMed Pharmaceuticals(Pvt.)LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/novamed-pharmaceuticalspvt-ltdGenerated 11 Nov 2026170comparable productsBelow peer median49 · 29%Near peer median67 · 39%Above peer median54 · 32%Company median price position+1.4%Lowest-price equivalents10Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsNovaMed Pharmaceuticals(Pvt.)LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/novamed-pharmaceuticalspvt-ltdGenerated 11 Nov 2026Bosch Pharmaceuticals (Pvt) Ltd.41 shared67% overlapNabiqasim Industries (Pvt) Ltd.,40 shared66% overlapBio-Labs(Pvt) Ltd39 shared64% overlapNeutro Pharma (Pvt.) Ltd.,39 shared64% overlapTABROS PHARMA (PVT). LTD.39 shared64% overlapGlobal Pharmaceuticals (Pvt.) Ltd.38 shared62% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet95 products
Injection30 products
Capsule21 products
Suspension17 products
Infusion7 products
Cream6 products
Syrup5 products
Drops2 products
Ointment1 products
Solution1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where NovaMed Pharmaceuticals(Pvt.)Ltd is priced against the market

170 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers129Distinct registrations among indexed, published, presentation-validated products only
Verified price observations186
Products with a verified price185
Products with multiple price observations1
Source records with multiple versions185
Latest portfolio source check12 Oct 2026
Latest effective price date5 Aug 2026
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

149 unique registration(s) · 185 indexed presentation(s) · 1 additional source-observed presentation(s) · 19 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Acinopril Plus Lisinopril 20 mg Tablet 28's 076830 PKR 916.10 PKR 32.72/tablet 🔒 Pharma Pro
Alar Artemether 20 mg Tablet 1x16's 049421 PKR 660.76 PKR 41.30/tablet 🔒 Pharma Pro
Alar DS Artemether 40 mg Tablet 1x8's 059909 PKR 545.14 PKR 68.14/tablet 🔒 Pharma Pro
Alar Once Artemether 80 mg Dispersible tablet 1x6's 059901 PKR 681.41 PKR 113.57/tablet No comparator
Alar Once Artemether 80 mg Dispersible tablet 1x4's 059901 PKR 454.29 PKR 113.57/tablet No comparator
Alar Plus Artemether 40 mg Dispersible tablet 1x8's 059902 PKR 545.14 PKR 68.14/tablet No comparator
Aldezole Metronidazole 500 mg/100 mL IV infusion 1's(100ml) 078720 PKR 189.93 — No comparator
Amilip Amlodipine 5 mg Tablet 20's 043467 PKR 216.82 PKR 10.84/tablet 🔒 Pharma Pro
Amilip Amlodipine 5 mg Tablet 10x10's 043467 PKR 997.35 PKR 9.97/tablet 🔒 Pharma Pro
Amilip Amlodipine 10 mg Tablet 20's 043468 PKR 410.92 PKR 20.55/tablet 🔒 Pharma Pro
Amilip Amlodipine 10 mg Tablet 10x10's 043468 PKR 1,776.47 PKR 17.76/tablet 🔒 Pharma Pro
Arithro Clarithromycin 250 mg Tablet 1x10's 043478 PKR 495.57 PKR 49.56/tablet 🔒 Pharma Pro
Arithro Clarithromycin 250 mg Tablet 100's 043478 PKR 4,286.82 PKR 42.87/tablet 🔒 Pharma Pro
Arithro Clarithromycin 500 mg Tablet 100's 043479 PKR 8,453.71 PKR 84.54/tablet 🔒 Pharma Pro
Arithro Clarithromycin 500 mg Tablet 10's 043479 PKR 918.88 PKR 91.89/tablet 🔒 Pharma Pro
Arithro Clarithromycin 125 mg/5 mL Dry suspension 60ml 047947 PKR 460.47 PKR 7.67/mL 🔒 Pharma Pro
Arithro Clarithromycin 500 mg Lyophilized injection 1's 110978 PKR 456.82 PKR 456.82/vial/unit No comparator
B-Loc Atenolol 50 mg Tablet 2x10's 043466 PKR 161.05 PKR 8.05/tablet 🔒 Pharma Pro
B-Loc Atenolol 50 mg Tablet 100's 043466 PKR 695.68 PKR 6.96/tablet 🔒 Pharma Pro
B-Loc Atenolol 100 mg Tablet 2x10's 043471 PKR 217.62 PKR 10.88/tablet 🔒 Pharma Pro
B-Loc Atenolol 100 mg Tablet 100's 043471 PKR 941.20 PKR 9.41/tablet 🔒 Pharma Pro
B-Loc Atenolol 25 mg Tablet 2x10's 076825 PKR 116.21 PKR 5.81/tablet 🔒 Pharma Pro
Babic Cephalexin 500 mg Capsule 12's 043476 PKR 294.31 PKR 24.53/capsule 🔒 Pharma Pro
Babic Cephalexin 250 mg Capsule 12's 043482 PKR 149.29 PKR 12.44/capsule 🔒 Pharma Pro
Babic Cephalexin 125 mg/5 mL Suspension 60ml 043486 PKR 108.77 PKR 1.81/mL 🔒 Pharma Pro
Babic Cephalexin 250 mg/5 mL Suspension 60ml 043493 PKR 189.82 PKR 3.16/mL 🔒 Pharma Pro
C-Doxil Capsules 500mgRegistry verified Cefadroxil as monohydrate — — — 043492Official source ↗ No indexed price — —
C-Doxil Suspension 125mg/5mlRegistry verified Cefadroxil as monohydrate — — — 043491Official source ↗ No indexed price — —
C-Doxil Suspension 250mgRegistry verified Cefadroxil as monohydrate — — — 043499Official source ↗ No indexed price — —
Cefcin Ceftriaxone 250 mg Injection 1's 045036 PKR 201.42 PKR 201.42/vial/unit 🔒 Pharma Pro
Cefcin Ceftriaxone 500 mg Injection 1's 045037 PKR 339.03 PKR 339.03/vial/unit 🔒 Pharma Pro
Cefcin Ceftriaxone 1 g Injection 1's 045038 PKR 640.17 PKR 640.17/vial/unit 🔒 Pharma Pro
Cefcin Ceftriaxone 250 mg Injection 1's 100874 PKR 162.18 PKR 162.18/vial/unit 🔒 Pharma Pro
Cefcin Ceftriaxone 500 mg Injection 1's 100875 PKR 272.97 PKR 272.97/vial/unit 🔒 Pharma Pro
Cefcin Ceftriaxone 1 g Injection 1's 100876 PKR 515.44 PKR 515.44/vial/unit 🔒 Pharma Pro
Ciprojan Ciprofloxacin 250 mg Tablet 1x10's 043487 PKR 268.44 PKR 26.84/tablet 🔒 Pharma Pro
Ciprojan Ciprofloxacin 250 mg Tablet 10x10's 043487 PKR 2,064.90 PKR 20.65/tablet 🔒 Pharma Pro
Ciprojan Ciprofloxacin 500 mg Tablet 1x10's 043500 PKR 371.69 PKR 37.17/tablet 🔒 Pharma Pro
Ciprojan Ciprofloxacin 500 mg Tablet 10x10's 043500 PKR 2,850.10 PKR 28.50/tablet 🔒 Pharma Pro
Ciprojan Ciprofloxacin 250 mg/5 mL Suspension 60ml 069248 PKR 325.72 PKR 5.43/mL 🔒 Pharma Pro
Ciprojan Ciprofloxacin 125 mg/5 mL Suspension 60ml 071450 PKR 222.36 PKR 3.71/mL 🔒 Pharma Pro
Ciprojan Ciprofloxacin 200 mg/100 mL IV infusion 1's 076973 PKR 206.49 PKR 206.49/vial/unit 🔒 Pharma Pro
Cipwell Ophtalmic Ciprofloxacin 3 mg/mL Solution 5ml 084888 PKR 189.46 PKR 37.89/mL No comparator
Clarin Loratadine 10 mg Tablet 1x10's 043607 PKR 148.70 PKR 14.87/tablet 🔒 Pharma Pro
Clarin Loratadine 10 mg Tablet 100's 043607 PKR 1,367.21 PKR 13.67/tablet 🔒 Pharma Pro
Clarin Loratadine 5 mg/5 mL Syrup 30ml 049419 PKR 51.64 PKR 1.72/mL 🔒 Pharma Pro
Clotrimed Clotrimazole 10 % Vaginal cream 1's(5gm) 100879 PKR 139.71 — No comparator
Clozin Clozapine 25 mg Tablet 5x10's 054150 PKR 1,651.92 PKR 33.04/tablet 🔒 Pharma Pro
Clozin Clozapine 100 mg Tablet 5x10's 054151 PKR 3,613.57 PKR 72.27/tablet 🔒 Pharma Pro
Dasvir Daclatasvir 60 mg Tablet 28's 088488 PKR 9,022.64 PKR 322.24/tablet 🔒 Pharma Pro
A to Z

All 74 NovaMed Pharmaceuticals brands in Pakistan

  • Acinopril Plus Lisinopril · 20 mg tablet
  • Alar Artemether · 20 mg tablet
  • Alar DS Artemether · 40 mg tablet
  • Alar Once Artemether · 80 mg tablet
  • Alar Plus Artemether · 40 mg tablet
  • Aldezole Metronidazole · 500 mg/100 mL infusion
  • Amilip Amlodipine · 10 mg tablet, 5 mg tablet
  • Arithro Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg injection
  • B-Loc Atenolol · 100 mg tablet, 25 mg tablet, 50 mg tablet
  • Babic Cephalexin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
  • Cefcin Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • Ciprojan Ciprofloxacin · 125 mg/5 mL suspension, 200 mg/100 mL infusion, 250 mg tablet
  • Cipwell Ophtalmic Ciprofloxacin · 3 mg/mL solution
  • Clarin Loratadine · 10 mg tablet, 5 mg/5 mL syrup
  • Clotrimed Clotrimazole · 10 % cream
  • Clozin Clozapine · 100 mg tablet, 25 mg tablet
  • Dasvir Daclatasvir · 60 mg tablet
  • Declocine Doxycycline · 100 mg capsule
  • Enta-B Entecavir · 0.5 mg tablet
  • Fer-P Iron polymaltose complex · 50 mg/5 mL syrup
  • Fer-P Plus Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet
  • Fitem Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
  • Fosbir Sofosbuvir · 90 mg tablet
  • Gempaz Empagliflozin · 10 mg tablet, 25 mg tablet
  • Genops Gentamicin · 0.3 % drops
  • Glazid MR Gliclazide · 30 mg tablet, 60 mg tablet
  • Glimin Gliclazide · 80 mg tablet
  • Glimin Forte Gliclazide · 160 mg tablet
  • Ibofen Ibuprofen · 100 mg/5 mL suspension, 400 mg/100 mL infusion
  • Icef Cefixime · 200 mg capsule
  • Iohex 350 Iohexol · 350 mg iodine/mL injection, 755 mg/mL (equiv. iodine 350 mg/mL) injection
  • Ironone Iron polymaltose complex, Polysaccharide iron complex · 150 mg capsule, 217.4 mg/5 mL syrup
  • Lamidin Lamivudine · 100 mg tablet
  • Letam Levetiracetam · 500 mg/5 mL injection
  • Lignox Lidocaine · 20 mg/mL injection
  • Limet Linezolid · 200 mg infusion
  • Linzod Linezolid · 200 mg/100 mL infusion, 400 mg tablet, 600 mg tablet
  • Lyvial 200 Lopinavir + Ritonavir · 200 mg + 50 mg tablet
  • Maxlox Moxifloxacin · 400 mg tablet
  • Merenium Meropenem · 1 g injection, 500 mg injection
  • Murocen Mupirocin · 2% ointment
  • Nov-C Ascorbic acid · 500 mg tablet
  • Novaterafine Terbinafine · 1 % cream
  • Novaxone Ceftriaxone · 2 g injection
  • Nufex Paediatric (Granules Cephalexin · 100 mg drops
  • O-Zole Omeprazole · 20 mg capsule, 40 mg capsule, 40 mg injection
  • Ofene Clomifene citrate · 50 mg tablet
  • Omixim Cefixime · 200 mg tablet
  • Onamed Fluconazole · 100 mg/50 mL infusion, 150 mg capsule
  • Oxefab Fluoxetine · 20 mg capsule
  • Oxylevo Levofloxacin · 250 mg tablet, 500 mg tablet
  • Pedisafe Zinc · 20 mg/5 mL syrup
  • Pixcito Apixaban · 2.5 mg tablet, 5 mg tablet
  • Provanol Propranolol · 10 mg tablet, 40 mg tablet
  • Pure-XIM Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
  • Quilynn-H Hydroxychloroquine · 200 mg tablet
  • Riba Ribavirin · 400 mg tablet, 600 mg tablet
  • Salazin Silver sulfadiazine · 1 % cream, 10 mg/g (1%) cream
  • Scibs Permethrin · 5% cream
  • Seaclop Clopidogrel · 75 mg tablet
  • Sim-Still Simvastatin · 10 mg tablet, 20 mg tablet
  • Sofonil Sofosbuvir · 400 mg tablet
  • Sofonil Plus Sofosbuvir + Velpatasvir · 400 mg + 100 mg tablet
  • Sunvit Cholecalciferol · 5 mg injection, 5 mg/mL injection
  • Supamol Paracetamol · 120 mg/5 mL suspension, 500 mg tablet
  • Supamol DS Paracetamol · 250 mg/5 mL suspension
  • Swiflin Cefazolin · 1 g injection, 250 mg injection, 500 mg injection
  • Taboxa Rivaroxaban · 10 mg tablet, 15 mg tablet, 2.5 mg tablet
  • Telday Plus Telmisartan + Amlodipine · 40 mg + 10 mg tablet, 40 mg + 5 mg tablet, 80 mg + 10 mg tablet
  • Traxart Tranexamic acid · 500 mg/5 mL injection
  • Tucana Cefixime · 100 mg/5 mL suspension, 200 mg/5 mL suspension, 400 mg capsule
  • Virjox Tenofovir disoproxil · 300 mg tablet, 300 mg (equivalent to tenofovir disoproxil 245 mg) tablet
  • Water for Injection Water for Injection · 10 mL injection, 5 mL injection
  • Zygrel Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg capsule
Questions

NovaMed Pharmaceuticals: common questions

How many products does NovaMed Pharmaceuticals have in Pakistan?

NovaMed Pharmaceuticals(Pvt.)Ltd has 185 registered medicine presentations in Pakistan, sold under 74 brands and covering 61 generic medicines.

What are the main brands of NovaMed Pharmaceuticals?

By number of registered strengths and packs, its largest brands are Taboxa (Rivaroxaban), Ciprojan (Ciprofloxacin), O-Zole (Omeprazole), Arithro (Clarithromycin) and Cefcin (Ceftriaxone). This is not a sales ranking.

Which therapy areas does NovaMed Pharmaceuticals cover?

The most products are in Anti-infectives (94), Cardiovascular (20), Hematology & thrombosis (16), Vitamins, minerals & nutrition (12) and Endocrine & metabolic (11).

Where can I see NovaMed Pharmaceuticals medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). NovaMed Pharmaceuticals(Pvt.)Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/novamed-pharmaceuticalspvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9